President & CEO, Board Member Resume Example

• Executive and business leader with record of tremendous success in creating revenue and profit growth in startup, turnaround, emerging, and volatile US and international markets. Solid understanding of the R&D process and taking products from concept to commercialization. Leverages global sales and marketing expertise, business acumen, and technical knowledge to identify untapped opportunities and bring new products to market that address unmet needs, generate industry leading growth, and strengthen competitive position. Builds high-performance, cohesive teams and develops individuals to leadership roles. Background in general, plastic, thoracic, vascular, cardiac, GI, orthopedic, dental, and neuro surgery, in the medical device space in large and small organizations and start-ups. Conversational fluency in Spanish. EXPERTISE
• Multi-site P&L / Operations Management Global Sales & Marketing Management
• Cross-functional / Cross-cultural Leadership International Business Development
• Product Development / Commercialization Investor / Board Relations
• Merger & Acquisition / Licensing Regulatory Affairs / Clinical Affairs
• Emerging Technologies & Markets Startup / Turnaround / Expansion
• Strategic Planning / Tactical Execution
• Direct to Patient/Consumer Marketing
• Key Opinion Leader Development
• Voice of customer based decision making

BIOHORIZONS -Senior Vice President, Global Sales & Marketing

SMITH & NEPHEW ORTHOPEDICS, -ice President Global Marketing, Professional Affairs and Business Development

ETHICON, INC.- Vice President Biosurgical Research and Development, 2005-2006 Group Director, Worldwide Marketing CV/ Director of Marketing Biosurgical Discovery

GENZYME-Director of Marketing, Cardiovascular Surgery | Sales and Marketing Director, Latin America
AMERICAN EXPRESS - Regional Account Manager
OAK TREE CAPITAL-Asset Manager

FIRST FLORIDA BANK - Commercial Real Estate Lending Officer

• Spearheaded company growth from $45 million to $120+ million annual revenue and from $8 million loss to $20+ million profit in 4 years, despite economic recession and declining to low-growth market.
• Negotiated agreement with Medtronic to distribute Infuse surgical bone graft product for use in dental surgery; generated $8 million in annual revenue and fostered strong relationships with oral surgeons.
• Commercial lead for $370 million Closure Medical acquisition; developed and negotiated multiple licensing agreements.
• Managed Biologic Portfolio including hard and soft tissue grafting, as well as human allograft and Infuse.
• Managed cradle-to-grave launch of PERI-LOC plating system; grew from zero to $45+ million in 2 years.
• Recognized with the Biohorizons Leadership Award in 2011 for outstanding contributions.